NPS Pharmaceuticals, Inc. (NPSP) Denies Any Contact From Shire Over Possible Takeover  
6/3/2014 8:09:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NPS Pharmaceuticals Inc. (NPSP) said it hasn’t received any overtures from Shire Plc (SHP) or any of the Dublin-based drug company’s representatives about a possible acquisition. Bloomberg News reported May 30 that NPS hadn’t been contacted by Shire, according to a personal familiar with the matter. The Financial Times’ Alphaville website reported on May 30 that Shire has held internal discussions about a possible cash offer for NPS, the Bedminster, New Jersey-based company that makes medicines for rare diseases. Shire has been adding drugs for rare diseases to lessen its dependence on its best-selling pill for attention deficit hyperactivity disorder.

Help employers find you! Check out all the jobs and post your resume.